Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
gptkb:acetylcholinesterase_inhibitor |
| gptkbp:ATCCode |
N07AA05
|
| gptkbp:CASNumber |
116-29-0
|
| gptkbp:chemicalFormula |
C10H16NO
|
| gptkbp:discoveredBy |
1950s
|
| gptkbp:eliminationHalfLife |
1.5–2 hours
|
| https://www.w3.org/2000/01/rdf-schema#label |
edrophonium
|
| gptkbp:IUPACName |
ethanamine, N-ethyl-N-(phenylmethyl)-, hydrochloride
|
| gptkbp:legalStatus |
prescription only
|
| gptkbp:mechanismOfAction |
inhibits acetylcholinesterase
|
| gptkbp:molecularWeight |
166.24 g/mol
|
| gptkbp:routeOfAdministration |
intravenous
|
| gptkbp:sideEffect |
hypotension
muscle cramps bradycardia increased salivation |
| gptkbp:synonym |
Reversol
Tensilon |
| gptkbp:usedFor |
diagnosis of myasthenia gravis
reversal of non-depolarizing neuromuscular blocking agents |
| gptkbp:bfsParent |
gptkb:tubocurarine
gptkb:Acetylcholinesterase |
| gptkbp:bfsLayer |
7
|